You must be logged in to post a comment.
When it comes to marketing a new drug in Europe, choosing the right name can be critical to the success […]
The “Nonproprietary Naming of Biological Products” draft guidance was published by the Food and Drug Administration (FDA) in August 2015 […]
In the highly competitive pharmaceutical industry, creating a brand name that stands out is crucial to gaining market share and […]
The Brazilian regulatory Agency, Anvisa (Agência Nacional de Vigilância Sanitária) issues market authorizations for medical devices and pharmaceuticals; exercises post-marketing […]
